Panel:  Investor’s Scienter Allegations Missed The Mark In Stock-Drop Suit

Mealey's (January 12, 2022, 2:38 PM EST) -- NEW YORK — A federal district court did not err in dismissing lead plaintiffs’ second amended complaint against a generic drug maker and certain of its current and former senior executives...
To view the full article, register now.